BOEHRINGER INGELHEIM FDA Approval NDA 011752

NDA 011752

BOEHRINGER INGELHEIM

FDA Drug Application

Application #011752

Application Sponsors

NDA 011752BOEHRINGER INGELHEIM

Marketing Status

Discontinued003
Discontinued004

Application Products

003TABLET, EXTENDED RELEASE;ORAL75MG0PRELUDINPHENMETRAZINE HYDROCHLORIDE
004TABLET, EXTENDED RELEASE;ORAL50MG0PRELUDINPHENMETRAZINE HYDROCHLORIDE

CDER Filings

BOEHRINGER INGELHEIM
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 11752
            [companyName] => BOEHRINGER INGELHEIM
            [docInserts] => ["",""]
            [products] => [{"drugName":"PRELUDIN","activeIngredients":"PHENMETRAZINE HYDROCHLORIDE","strength":"75MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"PRELUDIN","activeIngredients":"PHENMETRAZINE HYDROCHLORIDE","strength":"50MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"PRELUDIN","submission":"PHENMETRAZINE HYDROCHLORIDE","actionType":"75MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"PRELUDIN","submission":"PHENMETRAZINE HYDROCHLORIDE","actionType":"50MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.